this work is licensed under a creative commons attribution ...€¦ · cytochrome p450...

48
Copyright 2006, The Johns Hopkins University and James D. Yager. All rights reserved. Use of these materials permitted only in accordance with license rights granted. Materials provided “AS IS”; no representations or warranties provided. User assumes all responsibility for use, and all liability related thereto, and must independently review all materials for accuracy and efficacy. May contain materials owned by others. User is responsible for obtaining permissions for use from third parties as needed. This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License . Your use of this material constitutes acceptance of that license and the conditions of use of materials on this site.

Upload: others

Post on 13-Feb-2021

3 views

Category:

Documents


0 download

TRANSCRIPT

  • Copyright 2006, The Johns Hopkins University and James D. Yager. All rights reserved. Use of these materials

    permitted only in accordance with license rights granted. Materials provided “AS IS”; no representations or

    warranties provided. User assumes all responsibility for use, and all liability related thereto, and must independently

    review all materials for accuracy and efficacy. May contain materials owned by others. User is responsible for

    obtaining permissions for use from third parties as needed.

    This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this

    material constitutes acceptance of that license and the conditions of use of materials on this site.

    http://creativecommons.org/licenses/by-nc-sa/2.5/

  • Genetic and Environmental Factors AsDeterminants of Susceptibility to Disease

    Initiated during Development

    James D. Yager, PhDJohns Hopkins University

  • 3

    Lecture Outline

    General principles of toxicology and of developmentaltoxicologyEffects of exposure to diethylstilbestrol duringpregnancyCytochrome P450 biotransformation enzymes

    General functionCYP 2E1

    Function in alcohol metabolismGenetic polymorphismsChanges in expression during development

    Genetic, environmental life-style factors and risk

  • Section A

    General Principles of Toxicology and ofDevelopmental Toxicology

  • 5

    Susceptibility Factors

    Exposure

    AlteredStructure/Function

    Disease

    Exposure Assessment Risk Assessment

    InternalDose

    Biologically EffectiveDose

    Early BiologicalEffect

    ToxicodynamicsToxicokinetics

    The Toxicological Paradigm

  • 6

    Toxicological Process in Vivo

    Adapted from: Frazier. (1990) In Vitro Toxicology, 3, 349–357.

  • 7

    Developmental Toxicology

    A birth defect is "any anomaly, functional orstructural, that presents in infancy or later in life andis caused by events preceding birth, whetherinherited, or acquired.”

    March of Dimes

  • 8

    Pregnancy & Infant Health

    Social Factors

    Biological Factors Environmental Factors Genetics, gender, age Diet, tobacco, chemicals, radiation

    Behavior, community, medical care

    Birth Defects & Developmental

    Disorders

    Factors That Affect Pregnancy and Infant Health

    Source: March of Dimes

  • 9

    Selected Categories of Preventable Birth Defects

    Birth defects Estimated incidence Prevention measure

    I. Structural/metabol i c

    Neural tube defect s 1 in 1,600 births Folic acid

    II. Congenital infecti o n s

    Congenital syphilis 1 in 2,000 births Safe sex prior to conception/ treatment

    Congenital HIV 1 in 2,700 births Safe sex prior to conception/ avoid risks

    Congenital rubella syndr o m e 1 in 100,000 births Immunization

    III. Other

    Rh disease 1 in 1,400 births Immunoglobi n

    Fetal alcohol syndrome 1 in 1,000 births Avoid alcohol

    Note: All numbers are based on the best available estimates, which underestimate the incidence of many birth defects.Source: March of Dimes, Metropolitan Atlanta Congenital Defects Program and California Birth Defects Monitoring Program

  • 10

    Hereditary disease

    20%

    Cytogeneticdisease 4%

    Unknowncauses 70%

    Birth trauma and uterine factors 1%

    Maternal metabolic factors 1%

    Maternal infection 2%

    Drugs, chemicals, and radiation 2%

    Causes of Birth Defects

  • 11

    Effects of Alcohol on Pregnancy

    Fetal Alcohol Spectrum Disorder (FASD)MiscarriagePreterm birthLow birth weightFASARBD

    alcohol-related birth defectsARND

    alcohol-related neurodevelopmental disordersBirth complications

  • 12

    Principles of Developmental Toxicity: Toxic Windows

  • 13

    Critical Periods of HumanDevelopment for Teratogen Sensitivity

    Critical Periods of Human Development

    Source: Jones RE. Human Reproductive Biology. Academic Press, Inc. New York (1991)

  • 14

    Expected incidence of malformation of different organs and systems,the susceptibility of which varies according to the days of gestation

    Principles of Developmental Toxicity: Toxic Window

  • 15

    RadiationInfections Rubella virus Cytomegalovirus Herpes virus hominis Toxoplasmoisis SyphilisMaternal metabolic imbalances Alcoholism Cretinism Diabetes Folic acid deficiency Hyperthermia Phenylketonuria Rheumatic diseaseDrugs and chemicals Androgenic chemicals AntibioticsAnticancer drugs

    Anticonvulsants Diphenylhydantoin,trimethadioneAntithyroid drugsChelators PenicillamineChlorobiphenylsCigarette smokeCocaineCoumarin anticogulantsDiethylstilbesterolEthanolEthylene oxideIodidesLithiumMetals (Mercury(organic) LeadRetinoidsThalidomide

    Human Developmental Intoxicants

  • Section B

    Effects of Exposure to Diethylstilbestrol during Pregnancy

  • 17

    HO

    OH

    Estradiol

    OH

    HO

    Diethylstilbestrol

    Estrogens

  • 18

    Diethylstilbestrol (DES)

    Given to about 4.8 million pregnant women toprevent miscarriage

    Effects of in utero exposure on human female progeny

    Vaginal cancer in young women(1.4/1,000–10,000) Reproductive problems (18%)

    Effects of in utero exposure on human male progeny (3 times normal incidence)

    Anatomic abnormalities of the reproductivetract Altered semen—including decreased sperm

    density, count, and motility

  • 19

    1 2 3Critical period

    Human

    Estr

    ogen

    con

    cent

    ratio

    n

    Pregnancy (trimester)

    Critical Period for Exposure to DES

  • 20

    How Does DES Work?

    DES is a potent estrogen

  • 21

    Estrogens

    Oxidative metabolites

    Estrogen receptors

    mRNAs

    Specific P450s

    Specific proteins

    Nucleus

    DNA strand

    Mitochondria

    Mechanisms of Estrogen Receptor–Mediated Effects

  • 22

    OHHO

    Diethylstilbestrol

    OO

    DES Quinone very reactive

    P450-mediated

    Species differencesTissue differences

    DES Is Also Metabolized

  • 23

    Estradiol Is Also Metabolized

    O

    HO

    A B

    C D115

    14

    13

    12

    11

    98

    7

    65

    43

    2

    18

    17

    16

    OHCH3

    10

    OA B

    C D115

    14

    13

    12

    11

    98

    7

    653

    2

    18

    17

    16

    OHCH3

    10

    HOA B

    C D115

    14

    13

    12

    11

    98

    7

    653

    2

    18

    17

    16

    OHCH3

    10

    OH Estradiol Catechol

    Estradiol Quinone

    P450sEstradiol

    Source: Adapted from Zhu and Conney. (1998) Carcinogenesis.

  • 24

    OHOH

    HOO

    O

    GenisteinHO

    OH

    Estradiol

    Cl

    Cl

    C

    CCL3

    H

    o,p-DDTHO

    O

    Equilenin

    Environmental Chemicals with Hormone Activity

    Continued

  • 25

    Environmental Chemicals with Hormone Activity

    OHOH

    HOO

    O

    GenisteinHO

    OH

    Estradiol

    Cl

    Cl

    C

    CCL3

    H

    o,p-DDTHO

    O

    Equilenin

  • Section C

    Cytochrome P450 Biotransformation Enzymes: General Function and CYP 2E1 in AlcoholMetabolism

  • 27

    Cytochrome P450 (CYP) Enzymes

    Phase I biotransformation of xenobiotics(environmental chemicals) and endogenousmoleculesFunctions of CYPs

    Add or expose functional groups

  • 28

    TissueAccumulation

    Elimination

    No Biotransformation

    Expose/Add Functional

    Groups

    Conjugation

    Phase IProduct

    Phase IIProduct

    Elimination

    P 450s

    Xenobiotic

    Biotransformation of Xenobiotics

  • 29

    NO2

    OCH3 OH

    NO2

    + HCHO

    p- Nitroanisole p- Nitrophenol

    OCH2OH

    NO2

    Biotransformation Reactions

    Biotransformation reactions: exposing a functionalgroup

    Continued

  • 30

    Benzene

    Functional group introduced

    OH

    Phenol

    OSO3H

    O

    Glucuronide conjugation

    Glucuronic acid

    Phenyl glucuronide

    Phenyl sulfate

    Sulfate conjugation

    Biotransformation Reactions

    Biotransformation reactions: adding a functionalgroup

  • 31

    P450 GENE CHARACTERISTIC CHARACTERISTICSUBFAMILY INDUCER REACTION

    IA Polycyclic aromatic Benzo(a)pyrene hydroxylation hydrocarbons

    IIA Steroid hydroxylation IIB Phenobarbital Benzphetamine demythelation IIC Steroid hydroxylation IID Debrisoquine hydroxylation IIE Ethanol Ethanol hydroxylation IIIA Steroids Steroid hydroxylation

    Multiple Forms of P450

    Major Mammalian Cytochrome P450 Gene Families

  • 32

    Functions of CYP 2E1

    Metabolism of ethanolMetabolism of certain drugs and environmentalchemicals

    DrugsAcetaminophenChlorzoxazone

    Environmental chemicalsChloroformBenzeneToluene

    Inducible

  • 33

    Ethanol Acetaldehyde AcetateAlcohol dehydrogenase

    CYP 2E1

    Acetaldehyde dehydrogenase

    Damage to proteinsDamage to mitochondria

    Reactive oxygen species

    Reactive oxygen species

    Metabolism of Ethanol

  • Section D

    Cytochrome P450 Genetic Polymorphisms:Changes in Expression during Development

  • 35

    CYP 2E1 Gene Structure

    Lee et al. (1996). J Biol Chem, 12063–12067.

  • 36

    Cytochrome P450 2E1

    Genetic polymorphism that affects expressionChanges in expression during embryonic/fetaldevelopment

  • 37

    Human CYP 2E1 Polymorphism

    Use of restriction endonucleases and Southernblots to detect polymorphismDetection of 100 bp insertion in regulatory region ofP450 2E1 geneDetermination of functional effect of thepolymorphism

    Metabolism of chlorzoxazone metabolism to 6-hydroxychlorzoxazone in human subjects

  • 38

    5'-T^C T A G A-3'3'-A G A T C^T-5

    XbaI1500u#ER0681

    5'-T T T^ A A A-3'3'-A A A^T T T-5'

    DraI (AhaIII)1500u#ER0221

    Restriction Endonucleases

  • 39

    Polymorphism in the Upstream Region of CYP 2E1

    Source: McCarver D. G., Byun R., Hines R. N., et al. (1998) A genetic polymorphism in the regulatory sequences of human CYP2E1: associationwith increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake, Toxicol Appl Pharmacol, 152, 276–281.

  • 40

    Polymorphism in the Upstream Region of CYP 2E1

    Source: McCarver D. G., Byun R., Hines R. N., et al. (1998) A genetic polymorphism in the regulatory sequences of human CYP2E1: associationwith increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake, Toxicol Appl Pharmacol, 152, 276–281.

  • 41

    Chlorzoxazone Metabolism

    Administered 500 mgTook blood sample three hours later

  • 42

    Polymorphism vs. CYP 2E1 Metabolic Ability

    Chlo

    rzoxazone H

    ydro

    xyla

    tion Index

    Source: McCarver D. G., Byun R., Hines R. N., et al. (1998) A genetic polymorphism in the regulatory sequences of human CYP2E1: associationwith increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake, Toxicol Appl Pharmacol, 152, 276–281.

  • 43

    CYP 2E1 Expression vs. Age

    Source: Johnsurd E. K., Koukouritaki S. B., Divakaran K., et al. (2003). Human hepatic CYP2E1expression during development. J Pharmacol Exp Ther, 307, 402–407.

  • 44

    CYP 2E1 Expression: First Six Postnatal Months

    Source: Johnsurd E. K., Koukouritaki S. B., Divakaran K., et al. (2003). Human hepatic CYP2E1expression during development. J Pharmacol Exp Ther, 307, 402–407.

  • 45

    Summary of CYP 2E1 Changes in Expression During Development

    Changes in Expression during Development

    Source: Johnsurd E. K., Koukouritaki S. B., Divakaran K., et al. (2003). Human hepatic CYP2E1expression during development. J Pharmacol Exp Ther, 307, 402–407.

  • 46

    Electrophoretic Determination

    CYP 2E1 *1C and *1D genotypes—electrophoreticdetermination

    Source: Johnsurd E. K., Koukouritaki S. B., Divakaran K., et al. (2003). Human hepatic CYP2E1expression during development. J Pharmacol Exp Ther, 307, 402–407.

  • 47

    CYP 2E1 Genotype vs. Expression during Development

    Source: Johnsurd E. K., Koukouritaki S. B., Divakaran K., et al. (2003). Human hepatic CYP2E1expression during development. J Pharmacol Exp Ther, 307, 402–407.

  • 48

    RISK

    Genetic & Environmental/Life-Style Susceptibility Factors

    Genetic & Environmental/Life-StyleProtective Factors

    Genetic, Environmental, and Life-Style Factors and Risk